# Retrospective Evaluation of Patients Admitted to the Emergency Department Due to Anaphylaxis in Children: A Single-Center Study from Türkiye

**Authors:** Emre Aygün, Ezgi Yalçın Güngören, İrem Çırpıcı, Sevgi Sipahi Çimen

PMC · DOI: 10.3390/children13020203 · 2026-01-31

## TL;DR

This study finds that while acute care for pediatric anaphylaxis in emergency departments is generally good, there are significant gaps in post-discharge care, such as low rates of epinephrine auto-injector prescriptions and specialist referrals.

## Contribution

The study provides a detailed retrospective analysis of pediatric anaphylaxis management in a Turkish hospital, highlighting critical gaps in post-discharge care.

## Key findings

- Food allergy was the main cause of anaphylaxis in children, especially in infants.
- Only 7.8% of patients were prescribed epinephrine auto-injectors, and 15.7% were referred to allergists.
- Drug-induced anaphylaxis had the highest proportion of severe cases at 81.6%.

## Abstract

What are the main findings?
Pediatric anaphylaxis management in the emergency department shows sub-stantial gaps in timely epinephrine administration and discharge planning.Prescription rates of epinephrine auto-injectors and referrals to allergy specialists remain suboptimal despite guideline recommendations.

Pediatric anaphylaxis management in the emergency department shows sub-stantial gaps in timely epinephrine administration and discharge planning.

Prescription rates of epinephrine auto-injectors and referrals to allergy specialists remain suboptimal despite guideline recommendations.

What is the implication of the main finding?
Targeted educational and system-level interventions are needed to improve adherence to anaphylaxis management guidelines in pediatric emergency settings.Standardized discharge protocols may reduce preventable morbidity and re-current anaphylaxis in children.

Targeted educational and system-level interventions are needed to improve adherence to anaphylaxis management guidelines in pediatric emergency settings.

Standardized discharge protocols may reduce preventable morbidity and re-current anaphylaxis in children.

Background: Management of pediatric anaphylaxis in the emergency department remains clinically important. The research investigated pediatric anaphylaxis medical indicators together with physician adherence to international treatment protocols at a Turkish tertiary medical center. Methods: Between September 2014 and July 2025, 166 pediatric anaphylaxis patients were retrospectively reviewed for triggering factors, clinical findings, treatment approaches, and quality indicators. Results: The mean age of the patients was 7.4 ± 5.6 years. Food allergy was the main cause with 53%, followed by drugs with 24.7%. Food allergy in infants was 85.7%, while drug reactions in adolescents reached 37.2% (p < 0.001). Skin findings were present in 93.4% of the patients, and respiratory symptoms were present in 67.5% of the patients. Epinephrine was administered to 97.6% of patients, 95.2% of whom were given intramuscularly. The rate of epinephrine administration in the first 30 min was 61.1%. Drug-induced anaphylaxis showed the highest proportion of severe cases (81.6%, p < 0.001). A biphasic reaction was seen in 6%. The auto-injector prescription rate was 7.8%, and the allergist referral rate was 15.7%. No deaths were observed. Conclusions: While acute-phase management largely adheres to international guidelines, significant gaps persist in post-discharge care with low auto-injector prescription and allergist referral rates.

## Linked entities

- **Diseases:** anaphylaxis (MONDO:0100053)

## Full-text entities

- **Genes:** IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}
- **Diseases:** lip swelling (MESH:D008047), tachycardia (MESH:D013610), Urticaria (MESH:D014581), nausea (MESH:D009325), skin rash (MESH:D005076), Laryngeal edema (MESH:D007819), respiratory failure (MESH:D012131), Vomiting (MESH:D014839), hypoxia (MESH:D000860), Anaphylaxis (MESH:D000707), pruritus (MESH:D011537), bronchospasm (MESH:D001986), hypotension (MESH:D007022), atopic (MESH:C566404), laryngospasm (MESH:D007826), Shock (MESH:D012769), injury to (MESH:D014947), Asthma (MESH:D001249), mast cell activation syndrome (MESH:D000090267), abdominal pain (MESH:D015746), induced (MESH:D000092582), Neurological involvement (MESH:C538190), cow's milk allergies (MESH:D016269), shortness of breath (MESH:D004417), hereditary angioedema (MESH:D054179), AD (MESH:D000544), loss of consciousness (MESH:D014474), allergic diseases (MESH:D004342), heart condition (MESH:D006331), Wheezing (MESH:D012135), Drug-induced anaphylaxis (MESH:D000081015), atopic dermatitis (MESH:D003876), death (MESH:D003643), flushing (MESH:D005483), respiratory or cardiovascular symptoms (MESH:D012818), angioedema (MESH:D000799), Food allergy (MESH:D005512), tachypnea (MESH:D059246), heart rhythm disturbances (MESH:D020178), Bee stings (MESH:D000092422), AR (MESH:D013734), allergic rhinitis (MESH:D065631), Gastrointestinal involvement (MESH:D005767), Cardiovascular involvement (MESH:D002318), Biphasic reaction (MESH:D006967)
- **Chemicals:** oxygen (MESH:D010100), histamine (MESH:D006632), Adrenaline (MESH:D004837), CO2 (MESH:D002245), Beta-lactams (MESH:D047090), Penicillin (MESH:D010406), cephalosporin (MESH:D002511)
- **Species:** Arachis hypogaea (goober, species) [taxon 3818], Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939876/full.md

---
Source: https://tomesphere.com/paper/PMC12939876